This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (26)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Neurology, Other  • Public Health  • Substance Abuse/ Alcoholism  • Alert me on articles by topic  Social Bookmarking   What's this?

Results of Imaging Studies and Treatment Implications

Nora D. Volkow, MD; Joanna S. Fowler, PhD; Gene-Jack Wang, MD; James M. Swanson, PhD; Frank Telang, MD

Arch Neurol. 2007;64(11):1575-1579.

Imaging studies have provided new insights on the role of dopamine (DA) in drug abuse and addiction in the human brain. These studies have shown that the reinforcing effects of drugs of abuse in human beings are contingent not just on DA increases per se in the striatum (including the nucleus accumbens) but on the rate of DA increases. The faster the increases, the more intense the reinforcing effects. They have also shown that elevated levels of DA in the dorsal striatum are involved in the motivation to procure the drug when the addicted subject is exposed to stimuli associated with the drug (conditioned stimuli). In contrast, long-term drug use seems to be associated with decreased DA function, as evidenced by reductions in D2 DA receptors and DA release in the striatum in addicted subjects. Moreover, the reductions in D2 DA receptors in the striatum are associated with reduced activity of the orbitofrontal cortex (region involved with salience attribution and motivation and with compulsive behaviors) and of the cingulate gyrus (region involved with inhibitory control and impulsivity), which implicates deregulation of frontal regions by DA in the loss of control and compulsive drug intake that characterizes addiction. Because DA cells fire in response to salient stimuli and facilitate conditioned learning, their activation by drugs will be experienced as highly salient, driving the motivation to take the drug and further strengthening conditioned learning and producing automatic behaviors (compulsions and habits).

Author Affiliations: National Institute on Drug Abuse (Dr Volkow) and National Institute on Alcohol Abuse and Alcoholism (Drs Volkow and Telang), Bethesda, Maryland; Medical Department, Brookhaven National Laboratory, Upton, New York (Drs Fowler and Wang); and Department of Pediatrics, University of California, Irvine (Dr Swanson).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Which Cue to "Want?" Central Amygdala Opioid Activation Enhances and Focuses Incentive Salience on a Prepotent Reward Cue
Mahler and Berridge
J. Neurosci. 2009;29:6500-6513.
ABSTRACT | FULL TEXT  

Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study
Steeves et al.
Brain 2009;132:1376-1385.
ABSTRACT | FULL TEXT  

Methylphenidate-induced dendritic spine formation and {Delta}FosB expression in nucleus accumbens
Kim et al.
Proc. Natl. Acad. Sci. USA 2009;106:2915-2920.
ABSTRACT | FULL TEXT  

Overlapping neuronal circuits in addiction and obesity: evidence of systems pathology
Volkow et al.
Phil Trans R Soc B 2008;363:3191-3200.
ABSTRACT | FULL TEXT